Skip to main content
SpringerLink
Log in

Ist das Dilemma der Fibromyalgie durch die Leitlinie gelöst?

Is the dilemma of fibromyalgia solved by the guideline?

  • Leserbriefe
  • Published:
Der Schmerz Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Arnold B, Häuser W, Bernardy K et al. (2008) Multimodale Therapie des Fibromyalgiesyndroms. Schmerz 22: 334–338

    Article  PubMed  CAS  Google Scholar 

  2. Burckhardt CS, Goldenberg D, Crofford L et al. (2005) Guideline for the management of fibromyalgia syndrome pain in adults and children. APS clinical practice guidelines series, No 4. American Pain Society, Glenview, IL

  3. Eich W, Häuser W, Friedel E et al. (2008) Definition, Klassifikation und Diagnose des Fibromyalgiesyndroms. Schmerz 22: 255–266

    Article  PubMed  CAS  Google Scholar 

  4. Goldenberg D, Mayskiy M, Mossey C et al. (1996) A randomized, double-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia. Arthritis Rheum 39: 1852–1859

    Article  PubMed  CAS  Google Scholar 

  5. Langhorst JW, Häuser W, Irnich D et al. (2008) Komplementäre und alternative Therapien beim Fibromyalgiesyndrom. Schmerz 22: 324–333

    Article  PubMed  CAS  Google Scholar 

  6. Longstreth GF, Thompson WG, Chey WD et al. (2006) Functional bowel disorders. Gastroenterology 130: 1480–1491

    Article  PubMed  Google Scholar 

  7. McFarlane GJ (2005) Chronic widespread pain and fibromyalgia: should reports of increased mortality influence management? Curr Rheumatol Rep 7: 339–341

    Article  Google Scholar 

  8. Preskorn SH, Baker B (1997) Fatality associated with combined fluoxetine-amitryptiline therapy. JAMA 277: 1682

    Article  PubMed  CAS  Google Scholar 

  9. Sommer C, Häuser W, Berliner M et al. (2008) Medikamentöse Therapie des Fibromyalgiesyndroms. Schmerz 22: 313–323

    Article  PubMed  CAS  Google Scholar 

  10. Thieme K, Häuser W, Batra A et al. (2008) Psychotherapie bei Patienten mit Fibromyalgiesyndrom. Schmerz 22: 295–302

    Article  PubMed  CAS  Google Scholar 

  11. Wolfe F, Smythe HA, Yunus MB et al. (1990) The American College of Rheumatology criteria for the classification of fibromyalgia: report of the multicenter criteria committee. Arthritis Rheum 33: 160–172

    Article  PubMed  CAS  Google Scholar 

Download references

Interessenkonflikt

M. Mindach gibt an, dass kein Interessenkonflikt besteht.

W. Häuser: Referentenhonorare für die Fa. Janssen-Cilag, Mundipharma, Elli Lilly, Pfizer; Beratungshonorare für die Fa. Elli Lilly, Pfizer.

Author information

Authors and Affiliations

  1. Praxis für Neurologie und Psychiatrie, Humboldtstr. 5, 15232, Frankfurt, Deutschland

    M. Mindach

Authors
  1. M. Mindach
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Mindach.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mindach, M. Ist das Dilemma der Fibromyalgie durch die Leitlinie gelöst?. Schmerz 22, 685–688 (2008). https://doi.org/10.1007/s00482-008-0736-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00482-008-0736-7

Search

Navigation